Page last updated: 2024-08-26

nicotine and fluphenazine

nicotine has been researched along with fluphenazine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's0 (0.00)18.2507
2000's3 (42.86)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Tauberger, G1
Frontino, G1
Netter, P; Reuter, M1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1

Trials

1 trial(s) available for nicotine and fluphenazine

ArticleYear
The influence of personality on nicotine craving: a hierarchical multivariate statistical prediction model.
    Neuropsychobiology, 2001, Volume: 44, Issue:1

    Topics: Adult; Arousal; Cross-Over Studies; Dopamine; Fluphenazine; Humans; Limbic System; Lisuride; Male; Mesencephalon; Motivation; Nicotine; Personality; Personality Inventory; Smoking Cessation; Substance Withdrawal Syndrome; Substance-Related Disorders

2001

Other Studies

6 other study(ies) available for nicotine and fluphenazine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
[Inhibition of the central nervous vagus stimulating effect of nicotine by chlorpromazine, fluphenazine and imipramine].
    Arzneimittel-Forschung, 1971, Volume: 21, Issue:4

    Topics: Action Potentials; Animals; Cats; Chlorpromazine; Fluphenazine; Imipramine; Nicotine; Phrenic Nerve; Vagus Nerve

1971
[On the teratogenic effect of some substances].
    Archivio "Putti" di chirurgia degli organi di movimento, 1966, Volume: 21

    Topics: Abnormalities, Drug-Induced; Animals; Anti-Bacterial Agents; Chick Embryo; Fluphenazine; Nicotine

1966
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013